At Vogelzang Law, we represent and advocate for individuals diagnosed with cancer as a result of asbestos exposure. With more than 16 years of experience in mesothelioma and asbestos litigation, we have the specialized knowledge and resources needed to litigate complicated cases and the compassion necessary to advocate wholeheartedly for our clients.
Attorney Nicholas Vogelzang and his father, Dr. Nicholas Vogelzang, MD, FASCO, FACP, witnessed first-hand the devastation caused by a mesothelioma diagnosis. As a preeminent clinical oncologist for mesothelioma, Dr. Vogelzang revolutionized mesothelioma treatment when he discovered the first life-extending treatment, still in use today. Growing up with a parent dedicated to researching and treating rare forms of cancer such as mesothelioma inspired Nicholas Vogelzang to work and advocate for victims of the disease. After a number of years working for different firms, he founded Vogelzang Law in 2016 as a personal injury law firm dedicated to victims of mesothelioma in the United States.
As our client, you and your family will be served by our unified team of asbestos attorneys and additional staff through each phase of the litigation process. We understand the difficulties that come with a devastating asbestos-related diagnosis, and our goal is to lessen your load by providing top-notch legal representation.
#chicagolawyer #mesothelioma #asbestos
Company Details
- Employees
- 37
- Founded
- -
- Address
- 401 N. Michigan Avenue,
- Phone
- +1 312-466-1669
- Industry
- Law Practice
- NAICS
-
Offices of Lawyers
- Website
- vogelzanglaw.com
- HQ
- Chicago, Illinois
Vogelzang Law Questions
Vogelzang Law's helpline number is +1 312-466-1669
Vogelzang Law's website is vogelzanglaw.com
Vogelzang Law's LinkedIn profile is https://www.linkedin.com/company/vogelzanglaw
Vogelzang Law has
37 employees.
View email and phone details for 37
employees at Vogelzang Law.
Vogelzang Law's industry is
Law Practice
Vogelzang Law's categories are Law Practice
Vogelzang Law's founding year is 1998
